Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.78% | -177.07% | 29.91% | -10.19% | -10.32% |
| Total Depreciation and Amortization | -41.45% | -44.95% | -3.91% | 0.16% | -2.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -91.02% | 1,594.43% | -9.74% | 37.24% | 23.94% |
| Change in Net Operating Assets | 113.50% | 35.55% | -171.57% | 181.36% | -134.62% |
| Cash from Operations | 9.20% | -3.04% | 10.66% | 21.36% | -226.24% |
| Capital Expenditure | 75.00% | 52.00% | -25.00% | -17.65% | 91.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -314.79% | 93.03% | 169.63% | -133.92% | 2,605.71% |
| Cash from Investing | -316.14% | 96.37% | 167.22% | -134.47% | 1,285.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23,113.68% | 196.88% | 2,460.00% | -97.09% | -81.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23,113.68% | 196.88% | 2,460.00% | -97.09% | -81.55% |
| Foreign Exchange rate Adjustments | -133.33% | 3,850.00% | 77.78% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,810.55% | 75.35% | 69.03% | -459.16% | 191.10% |